🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
AUP
$AUPH
🔒 US EquitiesAurinia Pharmaceuticals Inc.
AVG HISTORICAL GAP
-0.07%
MAX GAP RECORD
-24.72%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $AUPH
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$AUPH
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 06, 2026 Earnings Release 2026-08-06 (UNDETERMINED) |
+0.00%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
+0.07%
|
| Feb 26, 2026 Earnings Release 2026-02-26 (BEFORE OPEN) |
+2.91%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (UNDETERMINED) |
+0.00%
|
| Jul 31, 2025 Earnings Release 2025-07-31 (AFTER CLOSE) |
+1.24%
|
| May 12, 2025 Earnings Release 2025-05-12 (BEFORE OPEN) |
+1.87%
|
| Feb 27, 2025 Earnings Release 2025-02-27 (BEFORE OPEN) |
-2.77%
|
| Nov 07, 2024 Earnings Release 2024-11-07 (BEFORE OPEN) |
+4.26%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.2%
Bullish Gaps (7)
Bearish Gaps (3)
Neutral / Flat (1)
📖 Intelligence Summary
Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗